| Multicenter Observational Study of PSC and IgG4-SC in China (NCT05463445) | RenJi Hospital | 2022-07-01 |
| Clinical Application of Annual Liver Multiscan and MRCP+ in Primary Sclerosing Cholangitis (NCT05462093) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2022-07-01 |
| A-LiNK: Improving Outcomes in Autoimmune Liver Disease (NCT05750498) | Children's Hospital Medical Center, Cincinnati | 2022-04-28 |
| Primary Sclerosing Cholangitis in Children (NCT04181138) | Arbor Research Collaborative for Health | 2021-12-30 |
| Evaluation of the Safety and Efficacy of HK-660S in Patients With Primary Sclerosing Cholangitis (NCT05866809) | CuromeBiosciences | 2021-10-28 |
| PSC Clinical Epidemiology in China (NCT04981756) | Beijing Friendship Hospital | 2021-04-07 |
| Efficacy of 24 Month of Bezafibrate in Primary Sclerosing Cholangitis With Persistent Cholestasis Despite Ursodeoxycholic Acid Therapy (NCT04309773) | Assistance Publique - Hôpitaux de Paris | 2021-04-06 |
| Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients (NCT04753996) | Mayo Clinic | 2021-03-08 |
| A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC) (NCT03678480) | HighTide Therapeutics (Hong Kong) Limited | 2021-03-01 |
| Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With Cirrhosis (NCT05181332) | West China Hospital | 2021-01-01 |
| A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) (NCT04663308) | Mirum Pharmaceuticals, Inc. | 2020-12-18 |
| CM-101 in PSC Patients -The SPRING Study (NCT04595825) | ChemomAb Ltd. | 2020-10-01 |
| Effect of Simvastatin on the Prognosis of Primary Primary Sclerosing Cholangitis (PSC) (NCT04133792) | Annika Bergquist | 2020-10-01 |
| Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC) (NCT04480840) | Pliant Therapeutics, Inc. | 2020-07-27 |
| Vancomycin for Primary Sclerosing Cholangitis (NCT03710122) | Elizabeth Carey | 2020-01-23 |
| A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSC (NCT04024813) | Gilead Sciences | 2019-11-12 |
| Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis (NCT04060147) | Gilead Sciences | 2019-10-17 |
| Vidofludimus Calcium for Primary Sclerosing Cholangitis (NCT03722576) | Elizabeth Carey | 2019-06-17 |
| Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management Study (NCT03951324) | Innovative Digestive Health Education and Research Inc | 2019-05-10 |
| Study of Cilofexor in Adults With Primary Sclerosing Cholangitis (NCT03890120) | Gilead Sciences | 2019-03-27 |
| Repeatability and Reproducibility of Quantitative MRCP (NCT03809559) | Perspectum | 2018-07-19 |
| Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis (NCT03561584) | Brigham and Women's Hospital | 2018-07-01 |
| norUrsodeoxycholic Acid vs Placebo in PSC (NCT03872921) | Dr. Falk Pharma GmbH | 2018-02-08 |
| A Research Study to Evaluate Safety and Efficacy of DUR-928 in Subjects With Primary Sclerosing Cholangitis (PSC) (NCT03394781) | Durect | 2018-01-22 |
| Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT (NCT03183570) | Stanford University | 2017-11-08 |
| A Study Of Ursolic Acid For Primary Sclerosing Cholangitis (NCT03216876) | University of California, Davis | 2017-09-01 |
| A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis (PSC) (NCT02978339) | John E. Eaton | 2017-06-09 |
| A Study of HTD1801 in Healthy Subjects (NCT03099603) | HighTide Therapeutics (Hong Kong) Limited | 2017-03-24 |
| MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease (NCT03178630) | Children's Hospital Medical Center, Cincinnati | 2017-02-20 |
| Paternally Inherited Phenotypes in Cholestasis (NCT03337074) | Guy's and St Thomas' NHS Foundation Trust | 2017-02-08 |
| Efficacy and Safety of Vedolizumab Intravenous (IV) in the Treatment of Primary Sclerosing Cholangitis in Subjects With Underlying Inflammatory Bowel Disease (NCT03035058) | Takeda | 2017-02-01 |
| MRI Based Biomarkers in Pediatric Autoimmune Liver Disease (NCT03175471) | Children's Hospital Medical Center, Cincinnati | 2017-01-17 |
| Biobank for Cholestatic Liver Diseases. (NCT03445585) | Mayo Clinic | 2017-01-01 |
| Umbilical Cord Mesenchymal Stem Cells in Primary Sclerosing Cholangitis (NCT03516006) | Fuzhou General Hospital | 2017-01-01 |
| Vancomycin Treatment in Recurrent PSC in Liver Transplant Patients (NCT03046901) | Ochsner Health System | 2016-12-07 |
| Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholangitis Without Cirrhosis (NCT02943460) | Gilead Sciences | 2016-11-29 |
| Quality of Life in Patients With Primary Sclerosing Cholangitis (NCT02712736) | Duke University | 2016-07-01 |
| PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Participants With Primary Sclerosing Cholangitis (NCT02653625) | Tobira Therapeutics, Inc. | 2016-03-14 |
| A Study of NGM282 in Patients With Primary Sclerosing Cholangitis (NCT02704364) | NGM Biopharmaceuticals, Inc | 2016-03-01 |
| The Effect of Bezafibrate on Cholestatic Itch (NCT02701166) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2016-02-01 |
| "Overlap Syndrome and PSC: Evaluating Role of Gut Microflora and Its Identification With Antibiotics in Children" (NCT03069976) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2016-01-01 |
| A Trial of BTT1023 in Patients With Primary Sclerosing Cholangitis (NCT02239211) | University of Birmingham | 2015-09-08 |
| Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis Patients (NCT02605213) | Tehran University of Medical Sciences | 2015-09-01 |
| A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis (NCT02464020) | University of Minnesota | 2015-07-01 |
| Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC) (NCT02247934) | Gilead Sciences | 2014-10-01 |
| Disease Status in Primary Sclerosing Cholangitis by Elastography (NCT02446665) | University Health Network, Toronto | 2014-10-01 |
| Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT (NCT01879735) | University of Aarhus | 2013-06-01 |
| NKT Role in the Regulation of the Inflammatory Bowel Disease (NCT02884557) | University Hospital, Lille | 2013-05-01 |
| Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy for PSC Biliary Strictures (NCT02736708) | University of Colorado, Denver | 2013-01-01 |
| Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis (NCT01755507) | Dr. Falk Pharma GmbH | 2012-12-01 |
| Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis (NCT01688024) | Li, Zhiping, M.D. | 2012-09-01 |
| Telomere Length and Other Parameters of Telomere Dysfunction in PSC and Colitis (NCT02247622) | Meir Medical Center | 2012-02-01 |
| Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy (NCT01549795) | Azienda Ospedaliera di Padova | 2012-01-01 |
| Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects (NCT01802073) | Stanford University | 2012-01-01 |
| Surveillance Study for Early Detection of Cholangiocarcinoma (CCA) in Primary Sclerosing Cholangitis (PSC) (NCT03041662) | Karolinska University Hospital | 2011-10-31 |
| Endomicroscopy in Primary Sclerosing Cholangitis Related Inflammatory Bowel Disease Surveillance (NCT01880606) | Karolinska University Hospital | 2011-08-01 |
| Short-term Stenting Versus Balloon Dilatation for Dominant Strictures in Primary Sclerosing Cholangitis (NCT01398917) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2011-05-01 |
| Pilot Study of Fenofibrate for PSC (NCT01142323) | University of Miami | 2010-10-01 |
| Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis (NCT01088607) | University of Tennessee | 2010-10-01 |
| Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin (NCT02137668) | Sacramento Pediatric Gastroenterology | 2010-07-01 |
| A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis (NCT01085760) | Mayo Clinic | 2010-02-01 |
| Surgical Reconstruction in Ulcerative Colitis With Primary Sclerosing Cholangitis (NCT01798953) | Sahlgrenska University Hospital | 2010-01-01 |
| Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC) (NCT00955149) | Mayo Clinic | 2009-08-01 |
| Endoscopic Ultrasound as an Early Diagnostic Tool for Primary Sclerosing Cholangitis (NCT01556412) | Tischendorf, Jens, M.D. | 2009-03-01 |
| Cholangioscopy Using Narrow Band Imaging (NBI) in Patients With Primary Sclerosing Cholangitis (PSC) Undergoing Endoscopic Retrograde Cholangiopancreatogram (ERCP) (NCT00951327) | Mayo Clinic | 2008-11-01 |
| Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin (NCT01322386) | Stanford University | 2007-05-01 |
| The Value of CT Cholangiography in Primary Sclerosing Cholangitis (NCT00588458) | Mayo Clinic | 2007-03-01 |
| Thalidomide for the Treatment of Primary Sclerosing Cholangitis (PSC) (NCT00953615) | Mayo Clinic | 2006-04-01 |
| Evaluation of DHA for the Treatment of PSC (NCT00325013) | Beth Israel Deaconess Medical Center | 2005-12-01 |
| Probiotics in Patients With Primary Sclerosing Cholangitis (NCT00161148) | UMC Utrecht | 2005-01-01 |
| NPDT Evaluation in Children With CFTR and (PSC) (NCT00179439) | Beth Israel Deaconess Medical Center | 2004-01-01 |
| Trial of High-dose Urso in Primary Sclerosing Cholangitis (NCT00059202) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2002-07-01 |
| NPD Measurements in PSC Patients (NCT00476814) | Hadassah Medical Organization | |